Chen Austin W, Yuen Leslie C, Ortiz-Declet Victor, Litrenta Jody, Maldonado David R, Domb Benjamin G
American Hip Institute, Westmont, Illinois, USA.
Hospital for Joint Diseases, New York University Langone Medical Center, New York City, New York, USA.
Am J Sports Med. 2018 Feb;46(2):297-304. doi: 10.1177/0363546517739566. Epub 2017 Nov 14.
Arthroscopic labral debridement in the hip can be an effective treatment for labral tears but has demonstrated inferior outcomes compared with labral repair. Thus, the role for labral debridement has become unclear. Hypothesis/Purpose: The purpose was to evaluate the outcomes of a selective debridement with labral preservation (SDLP) group with a minimum 5-year follow-up. It was hypothesized that, with narrow indications, SDLP would produce statistically improved patient-reported outcome (PRO) scores, comparable with those of a matched-pair labral repair control group.
Cohort study; Level of evidence, 3.
Data were collected on all patients undergoing primary hip arthroscopic surgery between February 2008 and September 2011. Exclusion criteria were acetabular or femoral head Outerbridge grade 4 chondral damage, preoperative Tnnis grade ≥2, workers' compensation claims, previous hip conditions, severe dysplasia (lateral center-edge angle <18°), or previous ipsilateral hip surgery. Patients who underwent arthroscopic labral debridement and had preoperative and minimum 5-year PRO scores, including the modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), and Hip Outcome Score-Sports-Specific Subscale (HOS-SSS) as well as the visual analog scale (VAS) for pain, were included. In a nested matched-pair comparison, the SDLP group was matched 1:1 to an arthroscopic labral repair control group based on age ±5 years, body mass index ±5 kg/m, sex, and Seldes tear type.
One hundred twenty-five hips were eligible for inclusion, of which 101 (80.8%) hips had a minimum 5-year follow-up. All PRO scores were significantly improved ( P < .001) at latest follow-up (mHHS, 63.4 to 82.4; NAHS, 57.4 to 83.6; HOS-SSS, 44.2 to 74.5). The mean VAS score decreased from 5.8 to 2.3 ( P < .001). The mean patient satisfaction score was 8.1. Four (4.0%) patients underwent second-look arthroscopic surgery (mean, 18.5 months), and 14 (13.9%) patients converted to total hip arthroplasty (mean, 46.9 months). In the matched-pair comparison, 69 in the SDLP group were matched 1:1 with those undergoing labral repair. Outcomes at latest follow-up of the SDLP group were comparable with those of the control group, respectively: mHHS, 83.0 vs 86.1 ( P = .084); NAHS, 85.0 vs 85.4 ( P = .415); HOS-SSS, 74.8 vs 76.8 ( P = .219); VAS, 2.3 vs 2.0 ( P = .277); international Hip Outcome Tool-12 (iHOT-12), 73.8 vs 76.4 ( P = .136); Short Form Health Survey-12 (SF-12) mental, 57.4 vs 55.1 ( P = .031); SF-12 physical, 48.7 vs 48.9 ( P = .357); Veterans RAND Health Survey-12 (VR-12) mental, 61.6 vs 59.8 ( P = .160); VR-12 physical, 50.1 vs 50.2 ( P = .340); and patient satisfaction, 8.0 vs 8.3 ( P = .211).
In select cases of stable labral tears, SDLP may allow the preservation of a functional labrum. At a minimum 5-year follow-up, SDLP using narrow indications produced favorable outcomes comparable with a matched-pair labral repair group.
髋关节镜下盂唇清创术可能是治疗盂唇撕裂的有效方法,但与盂唇修复术相比,其疗效较差。因此,盂唇清创术的作用尚不清楚。假设/目的:本研究旨在评估采用选择性清创并保留盂唇(SDLP)治疗的患者至少5年的随访结果。研究假设为,在严格的手术指征下,SDLP组患者报告的结局(PRO)评分在统计学上会得到改善,与配对的盂唇修复对照组相当。
队列研究;证据等级为3级。
收集2008年2月至2011年9月期间所有接受初次髋关节镜手术患者的数据。排除标准包括髋臼或股骨头Outerbridge 4级软骨损伤、术前Tennis分级≥2级、工伤赔偿申请、既往髋关节疾病、严重发育不良(外侧中心边缘角<18°)或既往同侧髋关节手术。纳入接受关节镜下盂唇清创术且有术前及至少5年PRO评分的患者,评分包括改良Harris髋关节评分(mHHS),非关节炎髋关节评分(NAHS),髋关节结局评分-运动特定子量表(HOS-SSS)以及疼痛视觉模拟量表(VAS)。在配对比较中,SDLP组按年龄±5岁、体重指数±5kg/m²、性别和Seldes撕裂类型与关节镜下盂唇修复对照组1:1配对。
125例髋关节符合纳入标准,其中101例(80.8%)进行了至少5年的随访。在最近一次随访时,所有PRO评分均显著改善(P < 0.001)(mHHS从63.4提高到82.4;NAHS从57.4提高到83.6;HOS-SSS从44.2提高到74.5)。VAS评分均值从5.8降至2.3(P < 0.001)。患者满意度评分均值为8.1。4例(4.0%)患者接受了二次关节镜检查手术(平均18.5个月),14例(13.9%)患者转为全髋关节置换术(平均46.9个月)。在配对比较中,SDLP组69例患者与盂唇修复组1:1配对。SDLP组最近一次随访时的结果与对照组相当,分别为:mHHS,83.0对86.1(P = 0.084);NAHS,85.0对85.4(P = 0.415);HOS-SSS,74.8对76.8(P = 0.219);VAS,2.3对2.0(P = 0.277);国际髋关节结局工具-12(iHOT-12),73.8对76.4(P = 0.136);简明健康调查-12(SF-12)心理评分,57.4对55.1(P = 0.031);SF-12生理评分,48.7对48.9(P = 0.357);退伍军人兰德健康调查-12(VR-12)心理评分,61.6对59.8(P = 0.160);VR-12生理评分,50.1对50.2(P = 0.340);患者满意度,8.0对8.3(P = 0.211)。
在稳定的盂唇撕裂的特定病例中,SDLP可能有助于保留功能性盂唇。在至少5年的随访中,采用严格手术指征的SDLP取得了与配对的盂唇修复组相当的良好效果。